Markers of insulin resistance in Polycystic ovary syndrome women: An update

被引:49
作者
Amisi, Chantal Anifa [1 ]
机构
[1] Univ Campus Biomed Rome, Endocrinol & Diabet Unit, Dept Med, Via Alvaro del Portillo 21, I-00128 Rome, Italy
关键词
Markers; Insulin resistance; Polycystic ovary syndrome; Emerging markers; Impaired glucose tolerance; HOMEOSTASIS MODEL ASSESSMENT; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; GLUCOSE-TOLERANCE TEST; BODY-FAT DISTRIBUTION; BETA-CELL FUNCTION; SERUM-LIPOPROTEIN RATIOS; NECROSIS-FACTOR-ALPHA; TO-HEIGHT RATIO;
D O I
10.4239/wjd.v13.i3.129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5%-10% of women of reproductive age. The importance of this syndrome lies in the magnitude of associated comorbidities: infertility, metabolic dysfunction, cardiovascular disease (CVD), plus psychological and oncological complications. Insulin resistance (IR) is a prominent feature of PCOS with a prevalence of 35%-80%. Without adequate management, IR with compensatory hyperinsulinemia contributes directly to reproductive dysfunction in women with PCOS. Furthermore, epidemiological data shows compelling evidence that PCOS is associated with an increased risk of impaired glucose tolerance, gestational diabetes mellitus and type 2 diabetes. In addition, metabolic dysfunction leads to a risk for CVD that increases with aging in women with PCOS. Indeed, the severity of IR in women with PCOS is associated with the amount of abdominal obesity, even in lean women with PCOS. Given these drastic implications, it is important to diagnose and treat insulin resistance as early as possible. Many markers have been proposed. However, quantitative assessment of IR in clinical practice remains a major challenge. The gold standard method for assessing insulin sensitivity is the hyperinsulinemic euglycemic glucose clamp. However, it is not used routinely because of the complexity of its procedure. Consequently, there has been an urgent need for surrogate markers of IR that are more applicable in large population-based epidemiological investigations. Despite this, many of them are either difficult to apply in routine clinical practice or useless for women with PCOS. Considering this difficulty, there is still a need for an accurate marker for easy, early detection and assessment of IR in women with PCOS. This review highlights markers of IR already used in women with PCOS, including new markers recently reported in literature, and it establishes a new classification for these markers.
引用
收藏
页码:129 / 149
页数:21
相关论文
共 242 条
  • [11] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [12] Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action
    Aroda, Vanita
    Ciaraldi, Theodore P.
    Chang, Sang-Ah
    Dahan, Michael H.
    Chang, R. Jeffrey
    Henry, Robert R.
    [J]. FERTILITY AND STERILITY, 2008, 89 (05) : 1200 - 1208
  • [13] Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial
    Aroda, Vanita R.
    Ciaraldi, Theodore P.
    Burke, Paivi
    Mudaliar, Sunder
    Clopton, Paul
    Phillips, Susan
    Chang, R. Jeffrey
    Henry, Robert R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) : 469 - 476
  • [14] Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: Amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance
    Arslanian, SA
    Lewy, V
    Danadian, K
    Saad, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) : 1555 - 1559
  • [15] Asante A, 2015, J REPROD MED, V60, P371
  • [16] Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis
    Ashwell, M.
    Gunn, P.
    Gibson, S.
    [J]. OBESITY REVIEWS, 2012, 13 (03) : 275 - 286
  • [17] Waist to Height Ratio Is a Simple and Effective Obesity Screening Tool for Cardiovascular Risk Factors: Analysis of Data from the British National Diet and Nutrition Survey of Adults Aged 19-64 Years
    Ashwell, Margaret
    Gibson, Sigrid
    [J]. OBESITY FACTS, 2009, 2 (02) : 97 - 103
  • [18] Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state
    Avignon, A
    Boegner, C
    Mariano-Goulart, D
    Colette, C
    Monnier, L
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (05) : 512 - 517
  • [19] Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance
    Bahceci, M
    Tuzcu, A
    Canoruc, N
    Tuzun, Y
    Kidir, V
    Aslan, C
    [J]. HORMONE RESEARCH, 2004, 62 (06) : 283 - 287
  • [20] Longterm management of Polycystic Ovarian Syndrome (PCOS)
    Bates, Gordon W.
    Legro, Richard S.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2013, 373 (1-2) : 91 - 97